PHARMACEUTICAL DATABASE
NEOPLASTIC
(Oncology.USA)
(Note: Some of these drugs may not be available
in the United Kingdom.)
The following information is not intended as a medical
advice. While every attempt is made to be accurate, we do not assume responsibility
for any mistakes, omissions
or the use of the pharmaceutical products listed in this database.
Contact: admin@hospitalweb.co.uk
RETURN
TO HOSPITAL WEB
DIRECTORY OF PHARMACEUTICAL COMPANIES
A B
C D E
F G H
I J K
L M N
O P Q
R S T
U V W
X Y Z
(Click on letter to go the
drugs starting with that letter.)
Arimidex. (UK)
Manufacturer: Zeneca.
Treatment Class: Neoplastic Conditions.
Indication: Advanced breast cancer.
Caelyx. (UK)
Manufacturer: Schering-Plough.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of Koposi’s sarcome connected to AIDS.
Casodex. (UK)
Manufacturer: Zeneca.
Treatment Class: Neoplastic Conditions.
Indication: Treatment, together with surgery or LHRH analogue, of advanced
prostatic cancer.
Cyprostat. (UK)
Manufacturer: Schering H.C.
Treatment Class: Neoplastic Conditions.
Indication: Treatment, long term and palliative, for prostatic cancer. Also,
treatment of testosterone flare,
linked to hot flushed and LHRH antagonists, connected to castration.
Decapeptyl SR. (UK)
Manufacturer: Speywood.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of advanced prostatic cancer.
Drogenil. (UK)
Manufacturer: Schering-Plough.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of advanced prostatic cancer.
Endoxana. (UK)
Manufacturer: Asta Medica.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of malignant disorders.
Estracyt. (UK)
Manufacturer: Pharmacia & Upjohn.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of prostatic cancer.
Estradurin. (UK)
Manufacturer: Pharmacia & Upjohn.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of prostatic cancer.
Ethyol (US).
Manufacturer: US Bioscience
Treatment Class: Oncology
Indication renal toxicity associated with repeated cisplatin therapy
Ethyol. (UK)
Manufacturer: Schering-Plough.
Treatment Class: Neoplastic Conditions.
Indication: Prophylaxis, in advanced ovarian carcinoma, of neutropenia infection
due to cyclophosphamide and cisplatin.
Fareston. (UK)
Manufacturer: Orion.
Treatment Class: Neoplastic Conditions.
Indication: Primary treatment of oestrogen-receptor dependent metastatic breast
cancer in postmenopausal patients.
Farlutal. (UK)
Manufacturer: Pharmacia & Upjohn.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of neoplasm's.
Femara (US).
Manufacturer: Novartis Pharmaceuticals
Treatment class: Oncology
Indication: Breast cancer
Femara. (UK)
Manufacturer: Ciba.
Treatment Class: Neoplastic Conditions.
Indication: Treatment for post-menopausal patients with advanced breast cancer
resistant to tamoxifen and other anti-oestrogens.
Gemzar (US).
Manufacturer: Lilly
Treatment class: Oncology
Indication: Pancreatic cancer
Gemzar. (UK)
Manufacturer: Lilly.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of non-small cell lung cancer.
Herceptin (US).
Manufacturer: Genentech, Inc.
Treatment class: Oncology
Indication: Approved for use in patients with metastatic breast cancer who
have tumors that overexpress the HER2
(human epidermal growth factor receptor2) protein
Honvan. (UK)
Manufacturer: Asta Medica.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of prostatic carcinoma.
Hycamtin (US).
Manufacturer: SmithKline Beecham
Treatment class: Oncology
Indication: Ovarian cancer; small cell lung cancer following the failure of
first-line chemotherapy
Hycamtin. (UK)
Manufacturer: SmithKline Beecham.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of metastatic ovarian cancer when other treatment has
been unsuccessful.
Lentaron. (UK)
Manufacturer: Ciba.
Treatment Class: Neoplastic Conditions.
Indication: Breast cancer in menopausal patients.
Maxtrex. (UK)
Manufacturer: Pharmacia & Upjohn.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of neoplastic conditions and severe psoriasis when other
treatment has been unsuccessful.
Megace. (UK)
Manufacturer: Bristol-Myers.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of endometrial or breast carcinoma.
Modrenal. (UK)
Manufacturer: Wanskerne.
Treatment Class: Neoplastic Conditions.
Indication: Treatment for post-menopausal patients with breast cancer.
Myleran. (UK)
Manufacturer: Glaxo Wellcome.
Treatment Class: Neoplastic Conditions.
Indication: Treatment for chronic grandulocytic leukaemia.
Mylotarg (US).
Manufacturer: American Home Products Corporation
Treatment class: Oncology
Indication: Treatment of patients aged 60 or older with CD33-positive relapsed
acute myeloid leukemia
Nilandron (US).
Manufacturer: Aventis
Treatment class: Oncology
Indication: Add-on therapy following surgical or chemical castration due to
prostate cancer
Nolvadex (US).
Manufacturer: AstraZeneca
Treatment class: Oncology
Indication: Breast cancer
Nolvadex-D. (UK)
Manufacturer: Zeneca.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of breast cancer.
Novantrone (US).
Manufacturer: Immunex Corporation
Treatment class: Oncology
Indication: Hormone-resistant prostate cancer and leukemia (approved); reduce
the number of relapses and slow down
disease progression in multiple sclerosis (not approved as of Mar 00)
Orimeten. (UK)
Manufacturer: Ciba.
Treatment Class: Neoplastic Conditions.
Indication: Treatment for post-menopausal or oophorectomised patients with
advanced breast carcinoma.
Also, advanced prostatic carcinoma as a palliative. Cushing’s syndrome.
Photofrin (US).
Manufacturer: Sanofi
Treatment class: Oncology
Indication: Esophageal cancer; Palliative management of advanced esophageal
cancer and microinvasive endobronchial
nonsmall cell lung cancer in patients for whom surgery or radiotherapy is
not an option
Primoteston Depot. (UK)
Manufacturer: Schering.
Treatment Class: Neoplastic Conditions.
Indication: Treatment for breast carcinoma.
Prostap SR. (UK)
Manufacturer: Wyeth.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of prostatic cancer.
Provera. (UK)
Manufacturer: Pharmacia & Upjohn.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of neoplasm's.
Puri-Nethol. (UK)
Manufacturer: Glaxo Wellcome.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of acute leukaemia in children.
Rituxan (US).
Manufacturer: Genentech and IDEC Pharmaceuticals
Treatment class: Oncology
Indication: Treatment of relapsed or refractory non-Hodgkin's lymphoma.
Sandostatin (US).
Manufacturer: Sandoz Pharmaceuticals
Treatment class: Endocrine and Metabolic
Indication: acromegaly, carcinoid tumors
Sandostatin. (UK)
Manufacturer: Sandoz.
Treatment Class: Neoplastic Conditions.
Indication: A palliative for gastroentero-pancreatic endocrine tumours and
carcinoid tumours.
Suprefact. (UK)
Manufacturer: Shire.
Treatment Class: Neoplastic Conditions.
Indication: Treatment to suppress testosterone in stage C or D prostatic carcinoma.
Tamofen. (UK)
Manufacturer: Pharmacia & Upjohn.
Treatment Class: Neoplastic Conditions.
Indication: Treatment for breast cancer.
Targretin (US).
Manufacturer: Ligand Pharmaceuticals Incorporated
Treatment class: Oncology
Indication: Treatment of cutaneous manifestations of early and advanced cutaneous
T-cell lymphoma in patients refractory to
at least one prior systemic therapy
Taxol (US).
Manufacturer: Bristol-Myers Squibb
Treatment class: Oncology
Indication: Breast, Ovarian Cancer
Taxol. (UK)
Manufacturer: BMS.
Treatment Class: Neoplastic Conditions.
Indication: Ovarian Cancer. Breast.
Taxotere (US).
Manufacturer: Aventis Pharmaceuticals
Treatment class: Oncology
Indication: Breast, Ovarian Cancer; locally advanced or metastatic non-small-cell
lung cancer in patients whose disease
has progressed after platinum-based chemotherapy.
Temodar (US).
Manufacturer: Schering-Plough Corp.
Treatment class: Oncology
Indication: Treatment of adult patients diagnosed with anaplastic astrocytoma
who have relapsed following chemotherapy
Thymitaq (US).
Manufacturer: Zarix, Inc.
Treatment class: Oncology.
Indication: For the treatment of patients with unresectable hepatocellular
carcinoma (not approved by FDA as of June 2000)
Tomudex. (UK)
Manufacturer: Zeneca.
Treatment Class: Neoplastic Conditions.
Indication: Relief of symptoms for advanced colorectal cancer.
Trelstar Depot (US).
Manufacturer: Pharmacia & Upjohn
Treatment class: Oncology
Indication: Palliative treatment of advanced prostate cancer in patients in
whom orchiectomy or estrogen administration
is not indicated or is unacceptable.
Uromitexan. (UK)
Manufacturer: Asta Medica.
Treatment Class: Neoplastic Conditions.
Indication: Treatment to prevent urothelial toxicity in patients given ifosfamide
or cyclophosphamide.
Utovlan. (UK)
Manufacturer: Searle.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of disseminate breast carcinoma.
Viadur (US)
Manufacturer: ALZA Corporation
Treatment class: Endocrine and Metabolic
Indication: Palliative treatment of advanced prostate cancer
Vesanoid (US).
Manufacturer: Roche.
Treatment class: Oncology.
Indication: Acute promyelocytic leukemia.
Virormone. (UK)
Manufacturer: Ferring.
Treatment Class: Neoplastic Conditions.
Indication: Treatment for post-menopausal patients with breast carcinoma.
Wellferon. (UK)
Manufacturer: Glaxo Wellcome.
Treatment Class: Neoplastic Conditions.
Indication: Treatment for chronic myeloid leukaemia. Also, hairy cell leukaemia.
Xeloda (US).
Manufacturer: Hoffmann-La Roche Inc.
Treatment class: Oncology.
Indication: Metastatic breast cancer resistant to standard chemotherapies.
Zoladex (US).
Manufacturer: AstraZeneca.
Treatment class: Oncology.
Indication: Breast cancer; prostate carcinoma; endometriosis.
Zoladex. (UK)
Manufacturer: Zeneca.
Treatment Class: Neoplastic Conditions.
Indication: Treatment of advanced breast cancer and prostrate cancer.
RETURN
TO HOSPITAL WEB